Most importantly, in mice, FcγR-TLR cross-talk did not affect the production of TNF-α, which is a pivotal cytokine in RA pathogenesis and currently the most successful target for the therapy of RA patients5. The gene discussed is FCGR2A; the disease is rheumatoid arthritis.